Previous 10 | Next 10 |
One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, plans to raise $75 million at a $424 million market cap. The...
There were no IPOs this past week, but initial filings from a biotech and a Chinese issuer are keeping the IPO market moving. After another strong week, the IPO Index is now up about 35% from its March lows. As we pointed out in our 1Q20 IPO Review, the first IPOs to emerge from the shutdown...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
TAMPA, Fla., April 01, 2020 (GLOBE NEWSWIRE) -- BRP Group, Inc. (“BRP Group” or the “Company”) (NASDAQ: BRP), a rapidly growing independent insurance distribution firm delivering tailored insurance solutions, today announced that Baldwin Krystyn Sherman Partners,...
The following slide deck was published by BRP Group, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Image source: The Motley Fool. BRP Group Inc (NASDAQ: BRP) Q4 2019 Earnings Call Mar 24, 2020 , 5:00 p.m. ET Operator Continue reading
BRP Group, Inc. (BRP) Q4 2019 Earnings Conference Call March 24, 2020, 05:00 PM ET Company Participants Bradford Hale - CAO Kristopher Wiebeck - CFO Trevor Baldwin - CEO Conference Call Participants Meyer Shields - KBW Greg Peters - Raymond James Elyse Greenspan - Wells...
BRP Group (NASDAQ: BRP ): Q4 Non-GAAP EPS of $0.06 beats by $0.02 ; GAAP EPS of -$0.48 misses by $0.45 . More news on: BRP Group, Inc., Earnings news and commentary, Financial stocks news, , Read more ...
- Fourth Quarter 2019 Revenue Grows 75% Year-Over-Year (12% Organic Growth) to $36.6 Million - - Full Year 2019 Revenue Grows 73% Year-Over-Year (10% Organic Growth) to $137.8 Million - - Pro Forma 2019 Revenue, Including...
This article is first in a series that provides an ongoing analysis of the changes made to BAMCO Inc.'s 13F stock portfolio on a quarterly basis. It is based on Ron Baron's regulatory 13F Form filed on 02/18/2020. The 13F portfolio value increased ~8% from $24.31B to $26.19B this quarter. Th...
News, Short Squeeze, Breakout and More Instantly...
BRP Group Inc. Company Name:
BRP Stock Symbol:
NYSE Market:
The Baldwin Group, the go-to-market brand name for The Baldwin Insurance Group, Inc. (formerly BRP Group, Inc.) (“Baldwin” or the “Company”) (NASDAQ: BRP), highlighted today that its Class A common stock will begin trading on NASDAQ under the new ticker symbol “...
The Baldwin Group, the go-to-market brand name for The Baldwin Insurance Group, Inc. (formerly BRP Group, Inc.) (“Baldwin,” “we” or “our”) (NASDAQ: BRP), today announced that its subsidiary, The Baldwin Insurance Group Holdings, LLC (“Baldwin Holdi...
The Baldwin Group, the go-to-market brand name for The Baldwin Insurance Group, Inc. (formerly BRP Group, Inc.) (“Baldwin”) (NASDAQ: BRP), announced today the pricing of the previously announced offering by its direct subsidiary The Baldwin Insurance Group Holdings, LLC (“Bal...